KERX is also a biotech buyout target in addition to hgsi.
NEW FILING OUT. MORE KERX INSIDER BUYS. CEO JUST BOUGHT SOME SHARES http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-SECText&TEXT=aHR0cDovL2lyLmludC53ZXN0bGF3YnVzaW5lc3MuY29tL2RvY3VtZW50L3YxLzAwMDExNDQyMDQtMTItMDIyNjE3L3htbA%3d%3d
It looks like the next target is KERX. What would be the buy-out offer?
$35 to $40 million in cash no debt with $140 million in carry forward tax credits and zerenex 5 months away from few approval. Trading at 2 x cash